It currently remains unclear whether tumor spread through airspaces (STAS) actually exist in vivo or are an artifact. The morphologies of STAS and tumor cell clusters in airway secretions collected from the segmental or lobar bronchus of resected lung adenocarcinomas and squamous cell carcinomas were compared among 48 patients. The EGFR status of tumor cell clusters in airway secretions was also compared with that of the main tumor in EGFR mutant adenocarcinomas. Tumor cell clusters were observed in the airway secretion cytology of ten patients (20.8%), and eight patients were adenocarcinoma (20.0% of adenocarcinoma). The morphology of STAS closely resembled that of tumor cell clusters detected in airway secretion cytology. The positive rates of airway secretion cytology were 83.3%, 100%, and 50% in papillary adenocarcinoma, micropapillary adenocarcinoma, and invasive mucinous adenocarcinoma, respectively. Among three EGFR mutant adenocarcinomas, the EGFR mutation subtypes of the main tumors in FFPE sections and tumor cell clusters in airway secretions were identical. These indicate that STAS may be detected in the airway secretion cytology. STAS is common in papillary or micropapillary adenocarcinoma and may spread as far as the segmental or lobar bronchus at the time of surgery.
The lung is an organ that is consistently in contact with the atmosphere. Primary lung cancer occurs under aerobic conditions and tumor cells may spread through the air for further invasion. Recent studies revealed that a micropapillary component unrelated to the primary lung cancer in the alveolar space was a prognostic factor for patients with pulmonary adenocarcinoma. A micropapillary component was defined as a small tumor cell cluster floating in the alveolar space with small papillary tufts lacking a fibrovascular core, 1, 2 and has been reported in 10-55% of pulmonary adenocarcinomas. 1, [3] [4] [5] Furthermore, micropapillary has been defined as one of the subtypes of pulmonary adenocarcinomas by the 2011 IASLC/ATS/ERS classification. 6 Presence of micropapillary cells is a poor prognostic factor, and patients with micropapillary cells are more likely to have local recurrence following surgical resection of lung cancer. 1, 2, 7, 8 Recent studies demonstrated that tumor cells dispersed through the airways in solid nests and/or a single cell pattern. These tumor cells, including micropapillary cells, are the so-called spread through air spaces (STAS). STAS is defined as the 'spread of lung cancer cells into air spaces in the lung parenchyma beyond the edge of the main tumor', which was described as a pattern of invasion. 9, 10 STAS is now recognized as a poor prognostic factor and risk factor for recurrence in adenocarcinoma and squamous cell carcinoma of the lung. [11] [12] [13] However, the existence of the STAS in vivo is still controversial, because tumor cell clusters floating in the alveolar space were detected in microscopic examination of formalin-fixed paraffin-embedded (FFPE) tumor tissue sections. STAS might be connected with the main tumor three-dimensionally or is an artifact produced during the processing of lung cancer specimens. [14] [15] [16] [17] Few studies have provided direct evidence to show that STAS exists in the airways. Therefore, the present study aimed to confirm the existence of STAS in airway secretions collected from the segmental or lobar bronchus of resected lung specimens.
MATERIALS AND METHODS
The present study was approved by the Institutional Review Board at the Kanagawa Cancer Center and was performed in accordance with the Declaration of Helsinki. Forty-eight out of 71 patients who underwent lobectomy or segmentectomy with systemic lymph node dissection for pulmonary adenocarcinoma or squamous cell carcinoma between June 20, 2013 and October 23, 2013 were included in this study. Patients who received preoperative therapy or had a positive tumor margin were excluded. Within 30 min of lung resection, an injection syringe was inserted into the bronchial stump in order to aspirate airway secretions presents at the lobar or segmental bronchus at which tumors were located ( Fig. 1 ). Direct smears of airway secretions were fixed routinely in 95% ethanol on two glass slides for more than 24 h and then stained using the Papanicolaou technique. The detection of any malignant cells was defined as positive cytology. The morphology of malignant cells detected in airway secretion cytology was compared with that of STAS in FFPE tissue sections. All histopathological diagnoses were made by a pathologist (T.Y.) based on FFPE tissue sections. After collecting samples of airway secretions, cold saline was dripped slowly (not injected) from a height of approximately 60-70 cm over the specimen into the bronchial lumen until the lung evenly inflated. Then, 10% formalin neutral buffer solution was added to the lung specimen using the same procedure as that for saline to fix specimens. After approximately 24 h of fixation by formalin, specimens were sliced into 3 to 5 mm thick segments. Tumor and normal lung tissues in the section which the tumor diameter was the largest were embedded in paraffin. Tissues were cut into approximately 4 mm thick sections. All sections were stained with hematoxylin and eosin for a pathological examination. The histological subtypes of lung adenocarcinomas were defined by the 2011 IASLC/ATS/ERS classification and subtyped semi-quantitatively by evaluating each component in 5% increments. 6 Based on the predominance of the different subtypes, lung adenocarcinoma was classified into adenocarcinoma in situ, minimally invasive adenocarcinoma, lepidic adenocarcinoma, acinar adenocarcinoma, papillary adenocarcinoma, micropapillary adenocarcinoma, solid adenocarcinoma, and invasive mucinous adenocarcinoma. 9 Tumor cells that dispersed through the airspaces with the formation of a tubular or solid pattern and single cell pattern, in addition to the typical micropapillary pattern, were included in STAS. 9, 10 CT was performed once a year at least after surgery, and head magnetic resonance imaging and PET-CT or bone scintigraphy were performed when recurrence was suspected. Locoregional recurrence was defined as recurrence in the ipsilateral chest and at the supraclavicular, neck, and axillary lymph nodes. Distant metastasis was defined as recurrence other than locoregional recurrence, which included that in the contralateral lung and the chest, brain, liver, adrenals, and bone. Lung cancer staging was based on the 7th Edition of the TNM Classification. 18 The epidermal growth factor receptor (EGFR) mutation gene status was analyzed for all primary lung cancer using tumor specimens obtained by surgical resection. Tumor DNA was extracted from FFPE tissues containing the tumor. The fragment method was used to detect the exon 19 deletion mutation, while the Cycleave method was used to detect the exon 18 mutation (G719X), exon 20 mutation (T790M), and exon 21 mutations (L858R and L861Q). 19 Exon 19 deletion mutation was detected after the mutation genes were amplified by polymerase chain reaction. Exon 18 mutation (G719X), exon 20 mutation (T790M), and exon 21 mutations (L858R and L861Q) were detected based on the basic principle of real-time polymerase chain reaction. The specific sequence of the amplified gene fragment was detected with a high sensitivity after hybridization of chimeric probe for the each mutation. An EGFR mutation analysis of tumors in surgically resected specimens was performed in a CAP and ISO15189 approved clinical laboratory (SRL, Tokyo, Japan).
The EGFR mutation gene status of malignant cells in the airway secretion cytology was analyzed for those who Figure 1 Within 30 min of lung resection, an injection syringe was inserted into the bronchial stump in order to aspirate airway secretions present at the segmental or lobar bronchus at which tumors were located.
harbored EGFR mutation in surgically resected specimens. DNA from cytological preparations of airway secretions was prepared as follows. After removing coverslips with xylol, targeted tumor cells were removed together with a thin dried film of Multi mount 480 (Matsunami Glass Ind., Tokyo, Japan) and cellular DNA was extracted with the DNA FFPE extraction kit (QIAamp, Qiagen, Hilden, Germany). An EGFR mutation analysis was performed with LH-MSA, namely, an analysis of hybridization products (loop-hybrid i.e. LH) between PCR-amplified DNA and appropriate LH probes with polyacrylamide electrophoresis as described previously. 20 Continuous variables were compared using the Student's t-test, and categorical variables were compared using Fisher's exact test. A P-value < 0.05 was considered significant. Patients provided informed consent.
RESULTS
The characteristics of 48 patients are shown in Table 1 . The mean CT and pathological tumor size were 31.8 (6-85) mm and 31.4 (9-85) mm, respectively, and 40 patients (83.3%) had primary lung adenocarcinoma. Ten patients had positive airway secretion cytology (20.8%). Among these patients, eight had primary lung adenocarcinoma (20.0% of adenocarcinoma) and two had primary squamous cell carcinoma (25.0% of squamous cell carcinoma).
STAS was observed in all FFPE tissue sections from patients with positive airway secretion cytology. The morphology of STAS in FFPE tissue sections and of tumor cell clusters in airway secretions closely resembled each other (Figs. 2, 3 ). Among the three EGFR mutant adenocarcinomas (the exon 21 L858R mutation for patient 6, and EGFR exon 19 deletion mutation for patients 4 and 5), the EGFR mutation subtypes of the tumor cell clusters in airway secretions were identical to those in the main tumors (Fig. 4) .
In Table 2 , the characteristics of eight patients with positive airway secretion cytology are compared with those of 32 patients with negative airway secretion cytology in pulmonary adenocarcinoma. Tumor sizes were slightly larger (P ¼ 0.058) and pathological stages were significantly more progressive (P ¼ 0.004) in the airway secretion cytology-positive group. The frequency of STAS in FFPE tissue sections was significantly higher in the airway secretion cytology-positive group (P < 0.001). Furthermore, the frequency of early recurrence (within 24 months of surgery) was significantly higher in the airway secretion cytologypositive group during the mean observation period of 30.6 months after surgery (P < 0.001). No significant differences were observed in recurrence patterns between the two groups (P ¼ 0.514). The sensitivity, specificity, and positive predictive value of airway secretion cytology for detecting STAS in FFPE tissue sections of primary lung adenocarcinoma among lung adenocarcinomas were 80%, 100%, and 100%, respectively.
The positive rates of airway secretion cytology were 83.3%, 100%, and 50% in papillary adenocarcinoma, micropapillary adenocarcinoma, and invasive mucinous adenocarcinoma, respectively (Fig. 5) . No malignant tumor cell clusters were detected in the airway secretion cytology of adenocarcinoma in situ, minimally invasive adenocarcinoma, acinar adenocarcinoma, or solid adenocarcinoma. The ratios that papillary and micropapillary components accounted for in a main tumor were higher in the airway secretion cytologypositive group (P < 0.001 and P ¼ 0.084, respectively), whereas that of lepidic component was lower (P ¼ 0.001).
DISCUSSION
This study suggests that STAS frequently spreads in the airways as far as the segmental or lobar bronchus at the time of surgery. In this study, STAS was detected in squamous cell carcinoma other than adenocarcinoma of the lung, as previously reported. 13 Prior to the present study, the presence of STAS in vivo in the alveolar space near the tumor was controversial for two reasons. The first reason was that STAS may be connected with the main tumor. Kamiya et al. previously reported that micropapillary cells appeared to be detached in FFPE sections, whereas most micropapillary tufts were connected with other micropapillary tufts and the main tumor in their serial section analysis. 14 Onozato et al. analyzed tumor cell clusters and islands of tumor cells detached in the alveolar space using an automated tissue sectioning machine and slide scanning system, and found that these tumor cells were connected with the main tumor in three-dimensional images. 15 The second reason was that tumor cell clusters floating in the alveolar space may be an artifact made during the pathological sectioning process. Tumor cells might be displaced by the knife along the plane of sectioning which was termed as spreading through a knife surface (STAKS). 16, 17 Because the morphology of STAS was almost the same as STAKS, it was difficult to determine whether it was STAS or STAKS. 16, 17 Kadota et al. distinguished STAS from artifacts when tumor cell clusters were scattered over tissue and at the edges of tissue sections, the edges of tumor cell clusters were jagged, and linear strips of cells were lifted off the alveolar wall. 11 Warth et al. defined tumor cell clusters as an artifact when they were not arranged in loose small groups or their distribution was inconsistent with the overall configuration of the circumferential tumor edge. 12 Morimoto et al. defined tumor cell clusters as an artifact when less than two clusters of tumor cells were present. 21 Since the real differentiation of STAS from an artifact is very difficult, a definitive judgment depends on pathologists. In order to prevent artifacts when processing lung specimens, we dripped saline and formalin slowly instead of injecting them rapidly, and this was expected to prevent tumor cells from peeling off the main tumor. Moreover, we prevent artifacts by cleaning the knife blade with tissue paper after each slice. 17 Since we did not observe any artifacts in the present study, there were no airway secretion cytology false-negative cases. It is important to know the EGFR status of lung cancer because it provides important information on the responsiveness of patients with unresectable advanced lung cancer to tyrosine kinase inhibitors as well as the prognosis of patients with resectable lung cancer following curative resection of the lung. [22] [23] [24] Moreover, it is often useful in a supplementary diagnosis to distinguish metachronous lung cancer from recurrent lung cancer by comparing the EGFR mutation statuses of the primary and secondary lung cancers. 25, 26 Yatabe et al. previously reported the homogeneous distribution of EGFR gene mutations in a single lung adenocarcinoma. 27 Based on this hypothesis, we compared EGFR mutation statuses between tumor cells in the main tumor and those in airway secretions among patients with EGFR mutant lung cancer. Because EGFR mutation was detected in atypical cells in airway secretion cytology in this study, they were confirmed to be tumor cells, not normal tissue cells as bronchial epithelial cells and macrophages which might be difficult to distinguish through microscopic morphology. The concordance of the EGFR mutation subtypes represented that tumor cells in airway secretion and those in the main tumor derived from same origin. Moreover, it implied that the tumor cells detected in airway secretions were originated from the main tumor and were considered to be STAS based on similarities in their microscopic morphologies. Previous studies reported that lymph-vascular invasion and pleural invasion were frequently detected in lung adenocarcinomas with micropapillary cells and the prognoses of patients with micropapillary pattern were poor. [1] [2] [3] [4] [5] 21 Nitadori et al. retrospectively analyzed p-stage I lung cancer and found that 35% of micropapillary component was a risk factor for local recurrence after limited surgery (wedge or segmental resection), and this risk was markedly higher if the tumor margin was 1 cm or less. 8 STAS was previously reported to be detected in 40% of resected lung adenocarcinomas, and STAS has been identified as a risk factor for locoregional recurrence among stage I lung adenocarcinomas following limited resection of the lung. 11 Islands of tumor cells detached in the alveolar space that are distinct from micropapillary cells are also a risk factor for recurrence, particularly within two years of surgery. 28 In the present study, six patients (75.0%) who were airway secretion cytology-positive (including three patients at pathological stage I) developed recurrence within two years of surgery. Therefore, airway secretion cytology may be a risk factor for early recurrence or a poor prognosis. Since only one out of eight patients (12.5%) developed recurrent tumor at the cut-end (data not shown), systemic adjuvant therapy was considered necessary after curative resection of lung cancer among airway secretion cytology-positive patients.
We intend to investigate treatment approaches after surgery for airway secretion cytology-positive patients. Kamiya et al. previously reported that non-lepidic and papillary adenocarcinoma were more common in lung adenocarcinomas with micropapillary cells. 14 Warth et al. also showed that papillary adenocarcinoma and micropapillary adenocarcinoma were frequently observed in the extensive type of STAS (>3 alveoli away from the main tumor mass), whereas the presence of STAS was very rare in lepidic adenocarcinoma. 12 In this study, we observed tumor cell clusters in airway secretions in papillary adenocarcinoma, micropapillary adenocarcinoma, and invasive mucinous adenocarcinoma, frequently. The frequency of the tumor cell cluster in airway secretion may differ according to the subtypes of the adenocarcinoma. Morimoto et al. previously found that non-integrated free tumor clusters were located apart from the main tumor, but did not exceed the diameter 21 ; however, the present study suggests that STAS spread as far as the segmental or lobar bronchus at the time of surgery. Thoracic surgeons will be provided with important information in order to select an appropriate procedure if STAS Ã indicates LH bands for mutant variants. M represents a 100 bp ladder marker, LH for loop-hybrid (LH) bands, PCR for PCR product bands. The EGFR mutation statuses of tumor cell clusters observed in the airway secretions of patients 4, 5, and 6 were identical to those of the main tumors in FFPE tissue sections. can be detected pre-or intra-operatively; however, there is currently no effectual methodology to detect STAS. Rudomina et al. reported that the detection of micropapillary tufts in cytology based on preoperative transbronchial aspiration and/or brushing is not specific for a diagnosis of lung adenocarcinomas with micropapillary cells because the positive predictive value of cytology was as low as 64%. 29 Although our study was based on a small number of samples, the positive predictive value for airway secretion cytology to detect STAS was high. The presence of STAS may be predicted efficiently by examining airway secretions at the segmental or lobar bronchus at which tumors are located before or during surgery. Some tumors might be vulnerable to the detachment of tumor cell clusters secondary to surgical manipulation. To elucidate the impact of the intraoperative manipulation of the gross lung specimen during surgery to STAS, we are now conducting a prospective study in our institution to detect STAS in preoperative cumulative sputum cytology. The biological behavior of the tumor cell cluster in airway secretion was unclear. Tumor cell cluster in airway secretion might represent an invasive component of the lung cancer because adenocarcinoma cells in pleural effusion and lymph node, an invasive part of the lung cancer, often showed STAS like morphology. Further molecular biochemical analyses of tumor cell cluster in airway secretion and STAS with respect to survival signal pathways as well as intrapulmonary metastasis, adhesion molecules, and gene expression are needed.
